APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Next Generation Sequencing (NGS) Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Next Generation Sequencing (NGS) Service Market Analysis and Forecast 2026-2032

Report ID 174520310512 August 2026174 pages

Choose your research edition.

Industry ResearchNext Generation Sequencing (NGS) Service Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Next Generation Sequencing (NGS) Service Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Next Generation Sequencing (NGS) Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Next Generation Sequencing (NGS) Service Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Next Generation Sequencing (NGS) Service Market Analysis and Forecast 2026-2032174 pages · $4,950 USD

Market perspective

The global Next Generation Sequencing (NGS) Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Next Generation Sequencing (NGS) Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Next Generation Sequencing (NGS) Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Next Generation Sequencing (NGS) Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Next Generation Sequencing (NGS) Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Next Generation Sequencing (NGS) Service include CLC Bio, GATC biotech AG, Macrogen, BGI (Beijing Genomics Institute), Illumina, Life Technology Corporation, EMC Corporation, Dnastar and 454 Life Sciences Corporation (Roche), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Next Generation Sequencing (NGS) Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Next Generation Sequencing (NGS) Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Next Generation Sequencing (NGS) Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Next Generation Sequencing (NGS) Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Next Generation Sequencing (NGS) Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Next Generation Sequencing (NGS) Service revenue, projected growth trends, production technology, application and end-user industry.

Next Generation Sequencing (NGS) Service Segment by Company

CLC Bio

GATC biotech AG

Macrogen

BGI (Beijing Genomics Institute)

Illumina

Life Technology Corporation

EMC Corporation

Dnastar

454 Life Sciences Corporation (Roche)

Agilent Technologies

Biomatters, Ltd

Next Generation Sequencing (NGS) Service Segment by Type

Targeted Sequencing & Resequencing

Whole Genome Sequencing

Whole Exome Sequencing

Next Generation Sequencing (NGS) Service Segment by Application

Whole-genome Sequencing

Exome Sequencing

Targeted Resequencing

De Novo Sequencing

RNA Sequencing

ChIP Sequencing

Methyl Sequencing

Others

Next Generation Sequencing (NGS) Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Next Generation Sequencing (NGS) Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Next Generation Sequencing (NGS) Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Next Generation Sequencing (NGS) Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Next Generation Sequencing (NGS) Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Next Generation Sequencing (NGS) Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Next Generation Sequencing (NGS) Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Next Generation Sequencing (NGS) Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Targeted Sequencing & Resequencing Major Player Table 3. Whole Genome Sequencing Major Player Table 4. Whole Exome Sequencing Major Player Table 5. Global Next Generation Sequencing (NGS) Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Whole-genome Sequencing Major Player Table 7. Exome Sequencing Major Player Table 8. Targeted Resequencing Major Player Table 9. De Novo Sequencing Major Player Table 10. RNA Sequencing Major Player Table 11. ChIP Sequencing Major Player Table 12. Methyl Sequencing Major Player Table 13. Others Major Player Table 14. Next Generation Sequencing (NGS) Service Industry Trends Table 15. Next Generation Sequencing (NGS) Service Industry Drivers Table 16. Next Generation Sequencing (NGS) Service Industry Opportunities and Challenges Table 17. Next Generation Sequencing (NGS) Service Industry Restraints Table 18. Global Next Generation Sequencing (NGS) Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 19. Global Next Generation Sequencing (NGS) Service Market Size by Region (2021-2026) & (US$ Million) Table 20. Global Next Generation Sequencing (NGS) Service Market Share by Region (2021-2026) Table 21. Global Next Generation Sequencing (NGS) Service Market Size by Region (2027-2032) & (US$ Million) Table 22. Global Next Generation Sequencing (NGS) Service Market Share by Region (2027-2032) Table 23. Global Next Generation Sequencing (NGS) Service Revenue by Players (US$ Million) & (2021-2026) Table 24. Global Next Generation Sequencing (NGS) Service Revenue Market Share by Players (2021-2026) Table 25. Global Next Generation Sequencing (NGS) Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 26. Global Next Generation Sequencing (NGS) Service Key Players Headquarters & Area Served Table 27. Global Next Generation Sequencing (NGS) Service Players, Product Type & Application Table 28. Global Next Generation Sequencing (NGS) Service Players Establishment Date Table 29. Global Players Market Concentration Ratio (CR5 and HHI) Table 30. Global Next Generation Sequencing (NGS) Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 31. Global Next Generation Sequencing (NGS) Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Next Generation Sequencing (NGS) Service Revenue by Type (2021-2026) & (US$ Million) Table 33. Global Next Generation Sequencing (NGS) Service Revenue by Type (2027-2032) & (US$ Million) Table 34. Global Next Generation Sequencing (NGS) Service Revenue Market Share by Type (2021-2026) Table 35. Global Next Generation Sequencing (NGS) Service Revenue Market Share by Type (2027-2032) Table 36. Global Next Generation Sequencing (NGS) Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Next Generation Sequencing (NGS) Service Revenue by Application (2021-2026) & (US$ Million) Table 38. Global Next Generation Sequencing (NGS) Service Revenue by Application (2027-2032) & (US$ Million) Table 39. Global Next Generation Sequencing (NGS) Service Revenue Market Share by Application (2021-2026) Table 40. Global Next Generation Sequencing (NGS) Service Revenue Market Share by Application (2027-2032) Table 41. CLC Bio Company Information Table 42. CLC Bio Business Overview Table 43. CLC Bio Next Generation Sequencing (NGS) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. CLC Bio Next Generation Sequencing (NGS) Service Product Portfolio Table 45. CLC Bio Recent Development Table 46. GATC biotech AG Company Information Table 47. GATC biotech AG Business Overview Table 48. GATC biotech AG Next Generation Sequencing (NGS) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. GATC biotech AG Next Generation Sequencing (NGS) Service Product Portfolio Table 50. GATC biotech AG Recent Development Table 51. Macrogen Company Information Table 52. Macrogen Business Overview Table 53. Macrogen Next Generation Sequencing (NGS) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Macrogen Next Generation Sequencing (NGS) Service Product Portfolio Table 55. Macrogen Recent Development Table 56. BGI (Beijing Genomics Institute) Company Information Table 57. BGI (Beijing Genomics Institute) Business Overview Table 58. BGI (Beijing Genomics Institute) Next Generation Sequencing (NGS) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. BGI (Beijing Genomics Institute) Next Generation Sequencing (NGS) Service Product Portfolio Table 60. BGI (Beijing Genomics Institute) Recent Development Table 61. Illumina Company Information Table 62. Illumina Business Overview Table 63. Illumina Next Generation Sequencing (NGS) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Illumina Next Generation Sequencing (NGS) Service Product Portfolio Table 65. Illumina Recent Development Table 66. Life Technology Corporation Company Information Table 67. Life Technology Corporation Business Overview Table 68. Life Technology Corporation Next Generation Sequencing (NGS) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Life Technology Corporation Next Generation Sequencing (NGS) Service Product Portfolio Table 70. Life Technology Corporation Recent Development Table 71. EMC Corporation Company Information Table 72. EMC Corporation Business Overview Table 73. EMC Corporation Next Generation Sequencing (NGS) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. EMC Corporation Next Generation Sequencing (NGS) Service Product Portfolio Table 75. EMC Corporation Recent Development Table 76. Dnastar Company Information Table 77. Dnastar Business Overview Table 78. Dnastar Next Generation Sequencing (NGS) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Dnastar Next Generation Sequencing (NGS) Service Product Portfolio Table 80. Dnastar Recent Development Table 81. 454 Life Sciences Corporation (Roche) Company Information Table 82. 454 Life Sciences Corporation (Roche) Business Overview Table 83. 454 Life Sciences Corporation (Roche) Next Generation Sequencing (NGS) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. 454 Life Sciences Corporation (Roche) Next Generation Sequencing (NGS) Service Product Portfolio Table 85. 454 Life Sciences Corporation (Roche) Recent Development Table 86. Agilent Technologies Company Information Table 87. Agilent Technologies Business Overview Table 88. Agilent Technologies Next Generation Sequencing (NGS) Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Agilent Technologies Next Generation Sequencing (NGS) Service Product Portfolio Table 90. Agilent Technologies Recent Development Table 91. Biomatters, Ltd Company Information Table 92. Biomatters, Ltd Business Overview Table 93. Biomatters, Ltd Next Generation Sequencing (NGS) Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Biomatters, Ltd Next Generation Sequencing (NGS) Service Product Portfolio Table 95. Biomatters, Ltd Recent Development Table 96. North America Next Generation Sequencing (NGS) Service Revenue by Type (2021-2026) & (US$ Million) Table 97. North America Next Generation Sequencing (NGS) Service Revenue by Type (2027-2032) & (US$ Million) Table 98. North America Next Generation Sequencing (NGS) Service Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Next Generation Sequencing (NGS) Service Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Next Generation Sequencing (NGS) Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Next Generation Sequencing (NGS) Service Revenue by Country (2021-2026) & (US$ Million) Table 102. North America Next Generation Sequencing (NGS) Service Revenue by Country (US$ Million) & (2027-2032) Table 103. Europe Next Generation Sequencing (NGS) Service Revenue by Type (2021-2026) & (US$ Million) Table 104. Europe Next Generation Sequencing (NGS) Service Revenue by Type (2027-2032) & (US$ Million) Table 105. Europe Next Generation Sequencing (NGS) Service Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Next Generation Sequencing (NGS) Service Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Next Generation Sequencing (NGS) Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Next Generation Sequencing (NGS) Service Revenue by Country (2021-2026) & (US$ Million) Table 109. Europe Next Generation Sequencing (NGS) Service Revenue by Country (US$ Million) & (2027-2032) Table 110. China Next Generation Sequencing (NGS) Service Revenue by Type (2021-2026) & (US$ Million) Table 111. China Next Generation Sequencing (NGS) Service Revenue by Type (2027-2032) & (US$ Million) Table 112. China Next Generation Sequencing (NGS) Service Revenue by Application (2021-2026) & (US$ Million) Table 113. China Next Generation Sequencing (NGS) Service Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Next Generation Sequencing (NGS) Service Revenue by Type (2021-2026) & (US$ Million) Table 115. Asia Next Generation Sequencing (NGS) Service Revenue by Type (2027-2032) & (US$ Million) Table 116. Asia Next Generation Sequencing (NGS) Service Revenue by Application (2021-2026) & (US$ Million) Table 117. Asia Next Generation Sequencing (NGS) Service Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Next Generation Sequencing (NGS) Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia Next Generation Sequencing (NGS) Service Revenue by Region (US$ Million) & (2021-2026) Table 120. Asia Next Generation Sequencing (NGS) Service Revenue by Region (US$ Million) & (2027-2032) Table 121. SAMEA Next Generation Sequencing (NGS) Service Revenue by Type (2021-2026) & (US$ Million) Table 122. SAMEA Next Generation Sequencing (NGS) Service Revenue by Type (2027-2032) & (US$ Million) Table 123. SAMEA Next Generation Sequencing (NGS) Service Revenue by Application (2021-2026) & (US$ Million) Table 124. SAMEA Next Generation Sequencing (NGS) Service Revenue by Application (2027-2032) & (US$ Million) Table 125. SAMEA Next Generation Sequencing (NGS) Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. SAMEA Next Generation Sequencing (NGS) Service Revenue by Country (2021-2026) & (US$ Million) Table 127. SAMEA Next Generation Sequencing (NGS) Service Revenue by Country (US$ Million) & (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Next Generation Sequencing (NGS) Service Image Figure 2. Global Next Generation Sequencing (NGS) Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Next Generation Sequencing (NGS) Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Targeted Sequencing & Resequencing Image Figure 5. Whole Genome Sequencing Image Figure 6. Whole Exome Sequencing Image Figure 7. Global Next Generation Sequencing (NGS) Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Next Generation Sequencing (NGS) Service Market Size Share 2021 VS 2025 VS 2032 Figure 9. Whole-genome Sequencing Image Figure 10. Exome Sequencing Image Figure 11. Targeted Resequencing Image Figure 12. De Novo Sequencing Image Figure 13. RNA Sequencing Image Figure 14. ChIP Sequencing Image Figure 15. Methyl Sequencing Image Figure 16. Others Image Figure 17. Global Next Generation Sequencing (NGS) Service Market Size (US$ Million) & (2021-2032) Figure 18. Global Next Generation Sequencing (NGS) Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Next Generation Sequencing (NGS) Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 20. Global Next Generation Sequencing (NGS) Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Next Generation Sequencing (NGS) Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Next Generation Sequencing (NGS) Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Next Generation Sequencing (NGS) Service Revenue Market Share by Type (2021-2032) Figure 25. Global Next Generation Sequencing (NGS) Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Next Generation Sequencing (NGS) Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 27. Global Next Generation Sequencing (NGS) Service Revenue Market Share by Application (2021-2032) Figure 28. North America Next Generation Sequencing (NGS) Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. North America Next Generation Sequencing (NGS) Service Revenue Share by Type (2021-2032) Figure 30. North America Next Generation Sequencing (NGS) Service Revenue Share by Application (2021-2032) Figure 31. North America Next Generation Sequencing (NGS) Service Revenue Share by Country (2021-2032) Figure 32. United States Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Canada Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Mexico Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Europe Next Generation Sequencing (NGS) Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 36. Europe Next Generation Sequencing (NGS) Service Revenue Share by Type (2021-2032) Figure 37. Europe Next Generation Sequencing (NGS) Service Revenue Share by Application (2021-2032) Figure 38. Europe Next Generation Sequencing (NGS) Service Revenue Share by Country (2021-2032) Figure 39. Germany Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. France Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. U.K. Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Italy Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Spain Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Russia Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Netherlands Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Nordic Countries Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. China Next Generation Sequencing (NGS) Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. China Next Generation Sequencing (NGS) Service Revenue Share by Type (2021-2032) Figure 49. China Next Generation Sequencing (NGS) Service Revenue Share by Application (2021-2032) Figure 50. Asia Next Generation Sequencing (NGS) Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 51. Asia Next Generation Sequencing (NGS) Service Revenue Share by Type (2021-2032) Figure 52. Asia Next Generation Sequencing (NGS) Service Revenue Share by Application (2021-2032) Figure 53. Asia Next Generation Sequencing (NGS) Service Revenue Share by Region (2021-2032) Figure 54. Japan Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. South Korea Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. India Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Australia Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Taiwan Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Southeast Asia Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. SAMEA Next Generation Sequencing (NGS) Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 61. SAMEA Next Generation Sequencing (NGS) Service Revenue Share by Type (2021-2032) Figure 62. SAMEA Next Generation Sequencing (NGS) Service Revenue Share by Application (2021-2032) Figure 63. SAMEA Next Generation Sequencing (NGS) Service Revenue Share by Country (2021-2032) Figure 64. Brazil Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Argentina Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Chile Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Colombia Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Peru Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Saudi Arabia Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Israel Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. UAE Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Turkey Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Iran Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Egypt Next Generation Sequencing (NGS) Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Targeted Sequencing & Resequencing
  • Whole Genome Sequencing
  • Whole Exome Sequencing
Applications
  • Whole-genome Sequencing
  • Exome Sequencing
  • Targeted Resequencing
  • De Novo Sequencing
  • RNA Sequencing
  • ChIP Sequencing
  • Methyl Sequencing
  • Others
Companies covered
  • CLC Bio
  • GATC biotech AG
  • Macrogen
  • BGI (Beijing Genomics Institute)
  • Illumina
  • Life Technology Corporation
  • EMC Corporation
  • Dnastar
  • 454 Life Sciences Corporation (Roche)
  • Agilent Technologies
  • Biomatters, Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Next Generation Sequencing (NGS) Service Market by Type
  3. 1.2.1 Global Next Generation Sequencing (NGS) Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Targeted Sequencing & Resequencing
  5. 1.2.3 Whole Genome Sequencing
  6. 1.2.4 Whole Exome Sequencing
  7. 1.3 Next Generation Sequencing (NGS) Service Market by Application
  8. 1.3.1 Global Next Generation Sequencing (NGS) Service Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Whole-genome Sequencing
  10. 1.3.3 Exome Sequencing
  11. 1.3.4 Targeted Resequencing
  12. 1.3.5 De Novo Sequencing
  13. 1.3.6 RNA Sequencing
  14. 1.3.7 ChIP Sequencing
  15. 1.3.8 Methyl Sequencing
  16. 1.3.9 Others
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Next Generation Sequencing (NGS) Service Market Dynamics
  1. 2.1 Next Generation Sequencing (NGS) Service Industry Trends
  2. 2.2 Next Generation Sequencing (NGS) Service Industry Drivers
  3. 2.3 Next Generation Sequencing (NGS) Service Industry Opportunities and Challenges
  4. 2.4 Next Generation Sequencing (NGS) Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Next Generation Sequencing (NGS) Service Market Perspective (2021-2032)
  2. 3.2 Global Next Generation Sequencing (NGS) Service Growth Trends by Region
  3. 3.2.1 Global Next Generation Sequencing (NGS) Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Next Generation Sequencing (NGS) Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Next Generation Sequencing (NGS) Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Next Generation Sequencing (NGS) Service Revenue by Players
  2. 4.1.1 Global Next Generation Sequencing (NGS) Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Next Generation Sequencing (NGS) Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Next Generation Sequencing (NGS) Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Next Generation Sequencing (NGS) Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Next Generation Sequencing (NGS) Service Key Players Headquarters & Area Served
  7. 4.4 Global Next Generation Sequencing (NGS) Service Players, Product Type & Application
  8. 4.5 Global Next Generation Sequencing (NGS) Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Next Generation Sequencing (NGS) Service Market CR5 and HHI
  11. 4.6.3 2025 Next Generation Sequencing (NGS) Service Tier 1, Tier 2, and Tier 3
5 Next Generation Sequencing (NGS) Service Market Size by Type
  1. 5.1 Global Next Generation Sequencing (NGS) Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Next Generation Sequencing (NGS) Service Revenue by Type (2021-2032)
  3. 5.3 Global Next Generation Sequencing (NGS) Service Revenue Market Share by Type (2021-2032)
6 Next Generation Sequencing (NGS) Service Market Size by Application
  1. 6.1 Global Next Generation Sequencing (NGS) Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Next Generation Sequencing (NGS) Service Revenue by Application (2021-2032)
  3. 6.3 Global Next Generation Sequencing (NGS) Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 CLC Bio
  2. 7.1.1 CLC Bio Company Information
  3. 7.1.2 CLC Bio Business Overview
  4. 7.1.3 CLC Bio Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 CLC Bio Next Generation Sequencing (NGS) Service Product Portfolio
  6. 7.1.5 CLC Bio Recent Developments
  7. 7.2 GATC biotech AG
  8. 7.2.1 GATC biotech AG Company Information
  9. 7.2.2 GATC biotech AG Business Overview
  10. 7.2.3 GATC biotech AG Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 GATC biotech AG Next Generation Sequencing (NGS) Service Product Portfolio
  12. 7.2.5 GATC biotech AG Recent Developments
  13. 7.3 Macrogen
  14. 7.3.1 Macrogen Company Information
  15. 7.3.2 Macrogen Business Overview
  16. 7.3.3 Macrogen Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Macrogen Next Generation Sequencing (NGS) Service Product Portfolio
  18. 7.3.5 Macrogen Recent Developments
  19. 7.4 BGI (Beijing Genomics Institute)
  20. 7.4.1 BGI (Beijing Genomics Institute) Company Information
  21. 7.4.2 BGI (Beijing Genomics Institute) Business Overview
  22. 7.4.3 BGI (Beijing Genomics Institute) Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 BGI (Beijing Genomics Institute) Next Generation Sequencing (NGS) Service Product Portfolio
  24. 7.4.5 BGI (Beijing Genomics Institute) Recent Developments
  25. 7.5 Illumina
  26. 7.5.1 Illumina Company Information
  27. 7.5.2 Illumina Business Overview
  28. 7.5.3 Illumina Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Illumina Next Generation Sequencing (NGS) Service Product Portfolio
  30. 7.5.5 Illumina Recent Developments
  31. 7.6 Life Technology Corporation
  32. 7.6.1 Life Technology Corporation Company Information
  33. 7.6.2 Life Technology Corporation Business Overview
  34. 7.6.3 Life Technology Corporation Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Life Technology Corporation Next Generation Sequencing (NGS) Service Product Portfolio
  36. 7.6.5 Life Technology Corporation Recent Developments
  37. 7.7 EMC Corporation
  38. 7.7.1 EMC Corporation Company Information
  39. 7.7.2 EMC Corporation Business Overview
  40. 7.7.3 EMC Corporation Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 EMC Corporation Next Generation Sequencing (NGS) Service Product Portfolio
  42. 7.7.5 EMC Corporation Recent Developments
  43. 7.8 Dnastar
  44. 7.8.1 Dnastar Company Information
  45. 7.8.2 Dnastar Business Overview
  46. 7.8.3 Dnastar Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Dnastar Next Generation Sequencing (NGS) Service Product Portfolio
  48. 7.8.5 Dnastar Recent Developments
  49. 7.9 454 Life Sciences Corporation (Roche)
  50. 7.9.1 454 Life Sciences Corporation (Roche) Company Information
  51. 7.9.2 454 Life Sciences Corporation (Roche) Business Overview
  52. 7.9.3 454 Life Sciences Corporation (Roche) Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 454 Life Sciences Corporation (Roche) Next Generation Sequencing (NGS) Service Product Portfolio
  54. 7.9.5 454 Life Sciences Corporation (Roche) Recent Developments
  55. 7.10 Agilent Technologies
  56. 7.10.1 Agilent Technologies Company Information
  57. 7.10.2 Agilent Technologies Business Overview
  58. 7.10.3 Agilent Technologies Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Agilent Technologies Next Generation Sequencing (NGS) Service Product Portfolio
  60. 7.10.5 Agilent Technologies Recent Developments
  61. 7.11 Biomatters, Ltd
  62. 7.11.1 Biomatters, Ltd Company Information
  63. 7.11.2 Biomatters, Ltd Business Overview
  64. 7.11.3 Biomatters, Ltd Next Generation Sequencing (NGS) Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Biomatters, Ltd Next Generation Sequencing (NGS) Service Product Portfolio
  66. 7.11.5 Biomatters, Ltd Recent Developments
8 North America
  1. 8.1 North America Next Generation Sequencing (NGS) Service Revenue (2021-2032)
  2. 8.2 North America Next Generation Sequencing (NGS) Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Next Generation Sequencing (NGS) Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Next Generation Sequencing (NGS) Service Revenue by Type (2027-2032)
  5. 8.3 North America Next Generation Sequencing (NGS) Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Next Generation Sequencing (NGS) Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Next Generation Sequencing (NGS) Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Next Generation Sequencing (NGS) Service Revenue by Application (2027-2032)
  9. 8.5 North America Next Generation Sequencing (NGS) Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Next Generation Sequencing (NGS) Service Revenue by Country
  11. 8.6.1 North America Next Generation Sequencing (NGS) Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Next Generation Sequencing (NGS) Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Next Generation Sequencing (NGS) Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Next Generation Sequencing (NGS) Service Revenue (2021-2032)
  2. 9.2 Europe Next Generation Sequencing (NGS) Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Next Generation Sequencing (NGS) Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Next Generation Sequencing (NGS) Service Revenue by Type (2027-2032)
  5. 9.3 Europe Next Generation Sequencing (NGS) Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Next Generation Sequencing (NGS) Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Next Generation Sequencing (NGS) Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Next Generation Sequencing (NGS) Service Revenue by Application (2027-2032)
  9. 9.5 Europe Next Generation Sequencing (NGS) Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Next Generation Sequencing (NGS) Service Revenue by Country
  11. 9.6.1 Europe Next Generation Sequencing (NGS) Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Next Generation Sequencing (NGS) Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Next Generation Sequencing (NGS) Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Next Generation Sequencing (NGS) Service Revenue (2021-2032)
  2. 10.2 China Next Generation Sequencing (NGS) Service Revenue by Type (2021-2032)
  3. 10.2.1 China Next Generation Sequencing (NGS) Service Revenue by Type (2021-2026)
  4. 10.2.2 China Next Generation Sequencing (NGS) Service Revenue by Type (2027-2032)
  5. 10.3 China Next Generation Sequencing (NGS) Service Revenue Share by Type (2021-2032)
  6. 10.4 China Next Generation Sequencing (NGS) Service Revenue by Application (2021-2032)
  7. 10.4.1 China Next Generation Sequencing (NGS) Service Revenue by Application (2021-2026)
  8. 10.4.2 China Next Generation Sequencing (NGS) Service Revenue by Application (2027-2032)
  9. 10.5 China Next Generation Sequencing (NGS) Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Next Generation Sequencing (NGS) Service Revenue (2021-2032)
  2. 11.2 Asia Next Generation Sequencing (NGS) Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Next Generation Sequencing (NGS) Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Next Generation Sequencing (NGS) Service Revenue by Type (2027-2032)
  5. 11.3 Asia Next Generation Sequencing (NGS) Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Next Generation Sequencing (NGS) Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Next Generation Sequencing (NGS) Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Next Generation Sequencing (NGS) Service Revenue by Application (2027-2032)
  9. 11.5 Asia Next Generation Sequencing (NGS) Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Next Generation Sequencing (NGS) Service Revenue by Country
  11. 11.6.1 Asia Next Generation Sequencing (NGS) Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Next Generation Sequencing (NGS) Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Next Generation Sequencing (NGS) Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Next Generation Sequencing (NGS) Service Revenue (2021-2032)
  2. 12.2 SAMEA Next Generation Sequencing (NGS) Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Next Generation Sequencing (NGS) Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Next Generation Sequencing (NGS) Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Next Generation Sequencing (NGS) Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Next Generation Sequencing (NGS) Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Next Generation Sequencing (NGS) Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Next Generation Sequencing (NGS) Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Next Generation Sequencing (NGS) Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Next Generation Sequencing (NGS) Service Revenue by Country
  11. 12.6.1 SAMEA Next Generation Sequencing (NGS) Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Next Generation Sequencing (NGS) Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Next Generation Sequencing (NGS) Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst